Natixis Vericel Corp Transaction History
Natixis
- $16 Billion
- Q4 2024
A detailed history of Natixis transactions in Vericel Corp stock. As of the latest transaction made, Natixis holds 31,047 shares of VCEL stock, worth $1.48 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
31,047Holding current value
$1.48 Million% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
293Shares Held
50.7MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$167 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$155 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$115 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$107 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.26B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...